Pancreatic Polypeptide Cells (PP cells), previously known as gamma cells (γ-cells) or F cells, constitute a distinct cell type found within the pancreatic islets, also known as the Islets of Langerhans. These cells play a pivotal role in the synthesis and regulation of pancreatic polypeptide (PP), from which they derive their name. The existence of the pancreatic islets, the residence of PP cells, was first identified in 1869 by the German pathological anatomist and scientist Paul Langerhans. Despite being integral components of the pancreas, PP cells are comparatively smaller when compared to other cell types within the organ. The proportions of these cells may vary across different animal species, but in humans, PP cells typically constitute less than 2% of the overall pancreatic islet cell population. PP cells play a crucial role in the regulation of plasma glucose levels by synthesizing and releasing pancreatic polypeptide (PP). Increased secretion of pancreatic polypeptide from PP cells has been observed to negatively impact insulin secretion, leading to anorexic effects on intestinal functionality. This phenomenon is associated with the inhibition of gut functions and a reduction in intestinal motor activity. In simpler terms, as the release of pancreatic polypeptide rises, the secretion of insulin, a key peptide hormone, tends to decrease. Additionally, pancreatic polypeptide contributes to the regulation of glycogen levels and the secretion of substances from gastrointestinal cells and tissues. Within the PP cells and their nucleus, cellular DNA plays a vital role in synthesizing various proteins that contribute to cellular functions. The production of pancreatic polypeptide is achieved through the transcription and translation of the PPY gene.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy